HNN3.0
Register
Register
Register

Project cooperationUpdated on 16 January 2026

AI-driven Digital Health Platform for Early Diagnosis and Remote Monitoring

PROFESSOR AND Technology transfer office director at Holy Spirit University of Kaslik

Jounieh, Lebanon

About

I am a Professor in Biomedical Engineering and Director of the Technology Transfer Office at a research-active university, with strong experience in AI for healthcare, personalized medicine, Pharma AI, and digital health systems, as well as innovation-to-impact pathways. My work bridges advanced research, clinical relevance, pharmaceutical innovation, and real-world deployment, aligned with Horizon Europe collaborative frameworks.

My research team specializes in the design, development, and validation of AI-enabled health technologies supporting personalized and precision medicine, including data-driven clinical decision support systems, AI-powered pharmacological analytics, digital therapeutics, and connected health platforms. We integrate multimodal data (clinical, biomedical signals, patient-reported outcomes, and treatment data) to enable patient-specific prediction, stratification, and optimization of therapies.

Key competencies of my research team include:

  • Artificial Intelligence & Machine Learning for healthcare and personalized medicine

  • Pharma AI: drug response modeling, treatment optimization, and data-driven pharmacological insights

  • Biomedical signal processing and clinical data analytics

  • Digital health systems, digital therapeutics, and remote patient monitoring

  • Human-centered design, usability, and clinical validation of AI-driven health technologies

  • Integration of AI solutions into clinical and pharmaceutical workflows

  • Technology transfer, IP strategy, exploitation planning, and impact generation

  • Academic–industry collaboration, living labs, and translational research environments

Proposed role in a Horizon Europe consortium:

  • Contributor or Work Package leader for AI development, personalized medicine, and Pharma AI components

  • Contributor for digital health system architecture, interoperability, and integration

  • Task leader for clinical and pharmacological validation, real-world evidence, and user-centered evaluation

  • Contributor to exploitation, innovation management, intellectual property, and sustainability strategy

  • Support for ethical, regulatory, and implementation-oriented tasks, including AI governance

Type of collaboration sought:

I am seeking to join a Horizon Europe Health Cluster consortium as a partner, collaborating with:

  • Coordinators leading Horizon Europe health and pharma-related proposals

  • Hospitals and clinical partners for validation and real-world deployment

  • Pharmaceutical, biotech, and medtech industry partners

  • Research centers with complementary expertise in AI, biomedical engineering, or pharmacology

I am particularly interested in projects aiming to translate AI-driven personalized medicine and Pharma AI innovations into clinically meaningful, patient-centered, and scalable healthcare solutions, with strong emphasis on validation, adoption, and long-term societal impact.

Similar opportunities

  • Project cooperation

    Innovation, Technology Transfer & Living Labs for Validation and Impact of Health Technologies

    Sandy Rihana

    PROFESSOR AND Technology transfer office director at Holy Spirit University of Kaslik

    Jounieh, Lebanon

  • Project cooperation

    Seeking partners for Horizon Europe Cluster 1 Health 2026

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Ofir Lindenbaum

    principal investigator at Bar Ilan University

    Tel Aviv, Israel

  • Project cooperation

    Research collaboration in NCD prevention, patient-centered health technologies and health system innovation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    MARILINA GARCIA ARANDA

    RESEARCHER, PROJECT COORDINATOR at Biomedical Research Institute of Málaga

    Marbella, Spain